Recently released pharmacovigilance documents by the European Medicines Agency (EMA) indicate that Pfizer was aware of substantial adverse side effects related to its COVID-19 vaccine as early as August 2022.
The documents reveal a total of 1,597,673 adverse events, one-third of which were classified as serious. A staggering 60% of cases were reported as βoutcome unknownβ or βnot recovered,β suggesting a prevalence of non-transient injuries.
Notably, Pfizer reported over 10,000 categories of diagnosis from the vaccine, many of them severe and rare. A breakdown of some of these includes:
- 73,542 cases of 264 categories of vascular disorders
- 696,508 cases of numerous categories of nervous system disorders
- Over 61,518 cases of more than 100 categories of eye disorders
- Over 47,000 ear disorders, including almost 16,000 cases of tinnitus
- Approximately 225,000 cases of skin and tissue disorders
- Roughly 190,000 cases of respiratory disorders
- Over 178,000 cases of reproductive or breast disorders
- Over 77,000 psychiatric disorders
- 3,711 cases of benign and malignant tumors
- Almost 127,000 cardiac disorders
- Over 100,000 blood and lymphatic disorders
